Singapore markets close in 2 hours 24 minutes
  • Straits Times Index

    3,238.48
    +36.59 (+1.14%)
     
  • Nikkei

    26,911.20
    +251.45 (+0.94%)
     
  • Hang Seng

    20,643.17
    +40.65 (+0.20%)
     
  • FTSE 100

    7,518.35
    +53.55 (+0.72%)
     
  • BTC-USD

    29,923.52
    -465.80 (-1.53%)
     
  • CMC Crypto 200

    672.48
    +429.80 (+177.11%)
     
  • S&P 500

    4,088.85
    +80.84 (+2.02%)
     
  • Dow

    32,654.59
    +431.17 (+1.34%)
     
  • Nasdaq

    11,984.52
    +321.73 (+2.76%)
     
  • Gold

    1,809.20
    -9.70 (-0.53%)
     
  • Crude Oil

    112.91
    +0.51 (+0.45%)
     
  • 10-Yr Bond

    2.9680
    0.0000 (0.00%)
     
  • FTSE Bursa Malaysia

    1,554.76
    +6.16 (+0.40%)
     
  • Jakarta Composite Index

    6,690.63
    +46.17 (+0.69%)
     
  • PSE Index

    6,705.66
    +111.00 (+1.68%)
     

Why Sesen Bio Stock Got Slammed Today

·2-min read
Why Sesen Bio Stock Got Slammed Today
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

The biotech, which concentrates on developing treatments for cancer, saw its share price dive by nearly 18% on the day. In August, the company's Biologics License Application (BLA) was rejected by the Food and Drug Administration (FDA). In its press release published just after the meeting, which Sesen Bio characterized as "productive," the company wrote that it now "believes it has greater clarity regarding the requirements for resubmission of the BLA and the trial design."

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting